Abstract. The level of immunoreactive calcitonin in the first produced breast milk was in totally thyroidectomized (TX) women 713 \ m=+-\ 307 pg-eq/ml (mean \ m=+-\sd 
munoextraction and gel chromatography of plasma collected during pregnancy and lactation from the TX women showed that the immunoreactive calcitonin present eluted in the region of monomeric calcitonin with both antiserum 1 and 2. In conclusion, high concentrations of high molecular weight forms of immunoreactive calcitonin have been demonstrated in milk from TX patients, most probably devoid of any calcitonin-producing thyroid C-cells. This points to a local production site in the mammary gland. Relatively high levels of immunoreactive calcitonin in plasma during pregnancy and lactation in TX women also indicate extrathyroidal production.
Immunoreactive calcitonin (iCT) in high concen¬ trations is present in human milk in forms larger than monomeric calcitonin (CT) (Bucht et al. 1983 ). In degradation experiments, these large forms were résistent to reduction, denaturation and treatment with acid in unextracted milk (Bucht et al. 1983 (Craig et al. 1982) . Therefore, the high molecular weight forms of iCT present in milk in high concentra¬ tions might constitute precursors, and this, in turn, would point to a local production of the hormone in the mammary gland.
To further elucidate the place of production, we measured iCT in milk from totally thyroidectomized (TX) women, i.e., in subjects where the major production site of CT had been removed.
iCT exists in low concentrations in plasma from normal subjects (Body & Heath 1983) , mainly in monomeric, dimeric and larger forms (Tobler et al. 1983; Bucht et al. 1985 Radioimmunoassay ofiCT ¡CT in milk and plasma was determined with a RIA earlier described in detail (Bucht et al. 1985) . Anti¬ serum 1 was raised in rabbits and was directed against the 17-32 sequence of human calcitonin (hCT). Syn¬ thetic hCT (Peninsula Lab Ine, San Carlos, CA, USA) was used as standard and for radioiodination. The detection limit of the assay was 8 pg/ml.
In addition, in this study a new antiserum (2) raised in rabbits against synthetic hCT (cibacalcin®) Immunoextraction iCT was extracted from milk from 3 of the 6 TX mothers and one of the control women with CT antiserum (1) coupled to a CNBr activated Sepharose 4B column as previously described for plasma (Bucht et al. 1985) . Plasma For markers and broken line, see Fig. 3 . days after delivery. The levels were highest in colostrum, and declined during the first 2 weeks in both TX and healthy women (Fig. 2 ).
Immunoextraction and gel chromatography of milk iCT After immunoextraction with antiserum 1, gel chromatography on Sephadex G-75 and RIA with antiserum 1, the iCT eluted as high molecular weight forms in the milk first produced (Fig. 3A) as well as in that produced 4 weeks after delivery (Fig. 3B ). iCT measured with antiserum 2 in the same fractions gave the same Chromatographie pattern but lower levels (Fig. 3A) . Treatment of immunoextracted iCT from milk with a denaturating agent disclosed that 40% of the high mole¬ cular weight iCT was an aggregate of monomeric CT, whereas 60% persisted as a form with an Mr of about 40000 (Fig. 4) . The small peak in the region of Vs (Fig. 4) was due to disturbances of urea in the RIA. iCT in plasma During the last trimester of pregnancy, plasma from the TX women contained 16 ± 6 pg-eq/ml (mean ± sd, = 6, median value 13 pg-eq/ml, one undetectable) and during lactation 14 ± 7 pg-eq/ml (N = 5, median value 13 pg-eq/ml, two undetectable). After cessation of lactation, the levels were all undetectable (N = 5). iCT levels in plasma from healthy women were 11 ± 4 pg-eq/ ml (N = 40, median value 9 pg-eq/ml, 43% undetectable) (Bucht et al. 1985) . When the me¬ dian value and mean ± SD were calculated, un¬ detectable levels were assigned the value of the detection limit of the assay (8 pg/ml).
Immunoextraction and gel chromatography ofplasma iCT Immunoextraction with antiserum 1 and gel chromatography of plasma from one woman dur¬ ing pregnancy, and pooled plasma collected dur¬ ing pregnancy and lactation from 3 of the women showed on RIA that iCT was eluted in the region of [125I]CT (Fig. 5) . As with milk iCT, antiserum 2 gave lower levels. From one of the mothers 40 ml of plasma for immunoextraction and gel chromatography was obtained after cessation of lactation. The plasma after extraction contained 0.7 pg-eq/ ml, which was a too low level for gel chromato¬ graphy.
Discussion iCT was present in milk from totally thyroidectomized (TX) woman in similar concentrations as in milk from healthy women. In both groups, the levels were highest in colostrum to decline during the first two weeks after delivery. This agrees with our earlier findings with a commercial RIA kit (INC, Stillwater, MN, USA) (Arver et al. 1984 ).
However, the total output of milk iCT is probably increasing with lactation time, since the milk vol¬ ume is multiplied about 40 times from day two after parturition to day 14 (Casey et al. 1985 Unextracted iCT in milk is resistant to denaturating and reducing agents (Bucht et al. 1983 (Edbrooke et al. 1985; Zajac et al. 1985) . iCT is also present in seminal plasma in large forms (Bucht et al. 1986a) , which contain the carboxy-terminal flanking pep¬ tide of the CT precursor.
In summary, similar high concentrations of high molecular weight forms of iCT were demon¬ strated in milk from TX women and healthy women. This confirms our earlier suggestion of locally produced CT. Monomer-like CT found in plasma from TX women during pregnancy and lactation also has to be of extrathyroidal origin.
